Study of the interaction of 1,4-dihydropyridine derivatives with glucocorticoid hormone receptors from the rat liver

Pharmacological Reports

Volumn 58, Issue 4, 2006, Pages 551-558

  Vaitkuviene, Aida ^a   Ulinskaite, Audrone ^a   Meškys, Rolandas ^a   Duburs, Gunars ^b   Kluša, Vija ^b,c   Liutkevičius, Evaldas ^a  

^a VILNIUS UNIVERSITY   (Lithuania)

^b LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

^c UNIVERSITY OF LATVIA   (Latvia)

Author keywords

1,4 dihydropyridines; Glucocorticoid receptor

Indexed keywords

1,4 DIHYDROPYRIDINE DERIVATIVE; A 74; ANION; CALCIUM ANTAGONIST; CARBATONE; CATION; CEREBROCRAST; CORTICOSTERONE; DEXAMETHASONE; DIETHONE; DIHYDROPYRIDINE DERIVATIVE; GAMMAPYRONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUTAPYRONE; J 6 163; NIFEDIPINE; OSI 1211; OSI 1580; OSI 2140; OSI 2780; OSI 4164; OSI 5003; OSI 7265; OSI 7724; PIRACETAM; RIODIPINE; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; HORMONE RECEPTOR INTERACTION; IC 50; IN VITRO STUDY; LIGAND BINDING; LIPOPHILICITY; LIVER CYTOSOL; MALE; NONHUMAN; RAT;

EID: 33748681122     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Akiyama H, Arai T, Kondo H, Tanno E, Haga C, Ikeda K: Cell mediators of inflammation in the Alzheimer's disease brain. Alzheimer Dis Assoc Disord, 2000, 14, Suppl 1, S47-S53.
2. Alban P, Hurd C, Dinda S, Khattree N, Moudgil VK: Differential regulation of retinoblastoma protein by hormonal and antihormonal agents in T47D breast cancer cells. J Steroid Biochem Mol Biol, 2001, 77, 135-141.
3. Barnes PJ, Adcock I: Anti-inflammatory action of steroids: molecular mechanisms. Trends Pharmacol Sci, 1993, 14, 436-441.
4. Bodine PV, Hajdu J, Litwack G: A new synthetic ether aminophosphoglyceride exhibits partial modulator activity towards the glucocorticoid receptor. Biochem Biophys Res Commun, 1994, 203, 408-415.
5. Braunsberg H, Hammond KD: Methods of steroid receptor calculation: an interlaboratory study. J Steroid Biochem, 1979, 11, 1561-1565.
6. DeRijk RH, Schaaf M, de Kloet ER: Glucocorticoid receptor variants: clinical implications. J Steroid Biochem Mol Biol, 2002, 81, 103-122.
7. Duburs GJ, Veveris MM, Weinheimer G, Bisenieks EA, Makarova NV, Kimenis AA, Uldrikis JR et al.: Synthesis and selective vasodilating properties of esters of 2,6-dimethyl-4-(2-difluoromethoxyphenyl)-1,4- dihydropyridine-3,4-dicarboxylic acid. Arzneim.-Forsch, 1989, 39, 1185-1189.
8. Flood JF, Morley JE, Roberts E: Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it, Proc Natl Acad Sci USA, 1992, 89, 1567-1571.
9. 3H]triamcinolone acetonide to glucocorticoid receptors in brain cytosol fractions of rats with intact adrenals. Neurochem Int, 1994, 24, 339-348.
10. 3H]dihydropyridine binding in A7r5 vascular smooth muscle cells. Am J Physiol, 1991, 261, C106-C114.
11. Henning SJ: A sensitive and convenient method for measurement of corticosterone in rat serum. Steroids, 1980, 35, 673-683.
12. Karpova MN, Germane SK, Tsebers G, Pankov OY, Klusha VE, Duburs GY, Bisenieks EA: Anticonvulsive activity of glutapyrone, a new type of derivative of amino acid-containing 1,4-dihydropyridine. Bull Exp Biol Med, 1993, 9, 283-286.
13. Klegeris A, Liutkevicius E, Mikalauskiene G, Duburs G, McGeer PL, Klusa V: Anti-inflammatory effects of cerebrocrast in a model of rat paw edema and on mononuclear THP-1 cells. Eur J Pharmacol, 2002, 441, 203-208.
14. Klusa V: Cerebrocrast (IOS-1.1212). Neuroprotectant, Cognition enhancer. Drugs Future, 1995, 20, 135-138.
15. Klusa V, Duburs G, Germane S, Muceniece R, Cebers G, Misane I, Bisenieks E et al.: Structure and activity peculiarities of cerebrocrast (IOS-1.1212), a novel type of CNS-modulating 1,4-dihydropyridine. Proc Latvian Acad Sci (Part B), 1992, 9, 51-55.
16. Klusa V, Germane S: Alcoholized maternal rat offspring: model for testing of physical and psychoemotional neurodeficit. Scand J Lab Anim Sci, 1996, 1, 403-409.
17. Liutkevičius E, Ulinskaitë A, Medkys F, Kraujelis K, Duburs G, Kluša V: Influence of different types of the 1,4-dihydropyridine derivatives on rat plasma corticosterone levels. Biomedical Lett, 1999, 60, 39-46.
18. Luisi BF, Xu WX, Otwinowski Z, Freedman LP, Yamamoto KR, Sigler PB: Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature, 1991, 352, 497-505.
19. McGeer PL, McGeer EG: The inflammatory response system of brain: implications for therapy of Alzheimer's and other neurodegenerative diseases. Brain Res Rev, 1995, 21, 195-218.
20. Misane I, Klusa V, Dambrova M, Germane S, Duburs G, Bisenieks E, Rimondini R, Ogren SO: "Atypical" neuromodulatory profile of glutapyrone, a representative of a novel 'class' of amino acid-containing dipeptide-mimicking 1,4-dihydropyridine (DHP) compounds: in vitro and in vivo studies. Eur Neuropsychopharmacol, 1998, 8, 329-347.
21. Mondadori C, Petsche F, Hausler A: The effect of nootropics on memory: new aspects for basic research. Pharmacopsychiatry, 1989, 22, 102-106.
22. Mortimore GE: Effect of insulin on potassium transfer in isolated rat liver. Am J Physiol, 1961, 200, 1315-1319.
23. Pascual-Le Tallec L, Lombes M: The mineralocorticoid receptor: a journey exploring its diversity and specificity of action. Mol Endocrinol, 2005, doi:10.1210/me.2005-0089.
24. Pratt WB, Toft DO: Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev, 1997, 18, 306-360.
25. Rose SPR: Cell-adhesion melecules, glucocorticoids and long-term-memory formation. Trends Neurosci, 1995, 18, 502-506.
26. Sakaue Y, Thompson EB: Characterization of two forms of glucocorticoid hormone-receptor complex separated by DEAE-cellulose column chromatography. Biochem Biophys Res Commun, 1977, 77, 533-541.
27. Schleimer RP, Claman HN, Oronsky A (Ed.): Anti-inflammatory Steroid Action: Basic and Clinical Aspects. Academic Press Inc, San Diego, 1989.
28. Sugaya K, Uz T, Kumar V, Manev H: New anti-inflammatory treatment strategy in Alzheimer's disease. Jpn J Pharmacol, 2000, 82, 85-94.
29. Vaitkuvienë A, Biziulevičienë G, Ulinskaitë A, Liutkevičius E: Protective effect of a 1,4-dihydropyridine derivative in a model of mouse paw edema. Biology, 2004, 2, 102-104.
30. Webb ML, Miller-Diener AS, Litwack G: Purification, characterization, and activation of the glucocorticoid-receptor complex from rat kidney cortex. Biochemistry, 1985, 24, 1946-1952.
31. Webster JI, Tonelli L, Sternberg EM: Neuroendocrine regulation of immunity. Annu Rev Immunol, 2002, 20, 125-163.